Otolaryngology · Annapolis, MD
NPI
1316035447
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
600 Ridgely Ave, Suite 110
Annapolis, MD, 21401
Phone (410) 573-9191
Groups this clinician bills Medicare through
Medicare paid, 2024
$544K
5,209 services
Medicare patients, 2024
1,067
Average age 76
Drug cost, 2024
$130K
2,081 prescriptions
Company payments, 2025
$1,302
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert B Meek III was code 99214 (office e&m - established), 1,068 times for 565 patients. In total Robert B Meek III billed 5,209 services in 71 codes, and Medicare paid $544K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,068 | 565 | $95.28 | $102K |
| 99213 Office E&M - Established | Office | 904 | 517 | $68.59 | $62K |
| 31579 Other Organ Systems | Office | 714 | 394 | $158.24 | $113K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 644 | 25 | $0.09 | $58.04 |
| 69210 Other Organ Systems | Office | 366 | 249 | $33.55 | $12K |
| 31231 Nasal/Sinus Endoscopy | Office | 326 | 215 | $145.21 | $47K |
| 99203 Office E&M - New | Office | 186 | 186 | $78.81 | $15K |
| 31575 Other Organ Systems | Office | 162 | 153 | $100.84 | $16K |
| 99204 Office E&M - New | Office | 134 | 134 | $128.21 | $17K |
| 99212 Office E&M - Established | Office | 80 | 66 | $39.04 | $3,123 |
| 92504 E&M - Miscellaneous | Office | 65 | 25 | $24.19 | $1,573 |
| 69801 Other Organ Systems | Office | 65 | 25 | $185.40 | $12K |
| 31574 Other Organ Systems | Office | 59 | 50 | $1,081.52 | $64K |
| 31237 Nasal/Sinus Endoscopy | Office | 45 | 19 | $292.89 | $13K |
| 99202 Office E&M - New | Office | 34 | 34 | $46.37 | $1,577 |
By year: 2022 $467K for 4,305 services; 2023 $596K for 5,793 services; 2024 $544K for 5,209 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert B Meek III prescribed most often to Medicare patients was Omeprazole, with 394 prescriptions and refills. In total Robert B Meek III wrote 2,081 Medicare prescriptions that cost $130K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 394 | 1,158 | 169 | $6,334 |
| Famotidine Generic | 252 | 745 | 131 | $3,450 |
| Rabeprazole Sodium Generic | 195 | 544 | 90 | $9,508 |
| Ipratropium Bromide Generic | 144 | 296 | 72 | $5,181 |
| Amitriptyline Hcl Generic | 120 | 308 | 68 | $2,235 |
| Methylprednisolone Generic | 99 | 99 | 77 | $583 |
| Fluocinolone Acetonide Oil Generic | 90 | 125 | 56 | $3,578 |
| Budesonide Generic | 85 | 208 | 45 | $30K |
| Mupirocin Generic | 75 | 75 | 66 | $559 |
| Azelastine Hcl Generic | 60 | 122 | 28 | $2,387 |
| Fluticasone Propionate Generic | 54 | 117 | 30 | $676 |
| Dexlansoprazole Dr Dexlansoprazole | 53 | 111 | 15 | $17K |
| Mometasone Furoate Generic | 52 | 138 | 32 | $8,321 |
| Prednisone Generic | 35 | 35 | 32 | $77.16 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 30 | 30 | 24 | $2,681 |
Brand drugs: 36 claims; generic drugs: 2,045 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert B Meek III $1,302 ($1,302 in general payments such as food, travel and fees) from 11 companies. The largest payer was GlaxoSmithKline, LLC. with $412.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 14 | $412 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $256 |
| Genzyme Corporation SNY | 4 | $193 |
| Optinose US, Inc. | 2 | $143 |
| Inspire Medical Systems, Inc. INSP | 1 | $101 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $87.37 |
| Aerin Medical Inc. | 1 | $41.83 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $18.4 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $18.34 |
| Integra LifeSciences Corporation IART | 1 | $18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.